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onic patterning, cell fate determination, and tissue ho-
meostasis. When secreted Wnt factors bind to their recep-
tors, a set of biochemical changes is set in motion,
ultimately resulting in the accumulation of -catenin and
its translocation to the nucleus. In the nucleus, -catenin
binds to members of the TCF/LEF family of transcription
factors, the most downstream components of the Wnt-
signaling pathway. Here, an overview is given of this tightly
regulated cascade, with particular emphasis on events that
take place in the nucleus.
THE TCF/LEF FAMILY OF
TRANSCRIPTION FACTORS
The founding members of the TCF/LEF family of tran-
scription factors, TCF-1 and LEF-1, were identified in
screens for T cell-specific transcription factors. TCF-1 was
identified by its ability to bind to the CD3 enhancer,
whereas LEF-1 was found in a screen for proteins binding to
the TCR enhancer and a site in the HIV LTR (Oosterwegel
et al., 1991; van de Wetering et al., 1991; Travis et al., 1991;
Waterman et al., 1991). In more recent years, two additional
family members were identified in mammals: TCF-3 and
TCF-4 (Korinek et al., 1998a). The Drosophila genome only
contains one TCF gene, called dtcf or pangolin (Brunner et
al., 1997; van de Wetering et al., 1997). Similarly, a single
gene resides in the genome of the nematode Caenorhabditis
elegans, Pop-1 (Lin et al., 1995).
Proteins of the TCF/LEF family contain an 80-amino-acid
high mobility group (HMG) box. HMG boxes bind DNA as
monomers and can do so (Grosschedl et al., 1994; Laudet et
al., 1993) in a sequence-specific manner (Laudet et al.,
1993). The TCF consensus recognition sequence is remark-
ably conserved between the family members and comprises
AGATCAAAGGG (van de Wetering et al., 1991; Giese et
al., 1991; van Beest et al., 2000). The HMG box not only
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All rights reserved.mediates DNA sequence recognition, but coincidently in-
duces a dramatic bend in the DNA (Giese et al., 1992;
Dooijes et al., 1993). By doing so, HMG boxes may coordi-
nate the binding of other transcription factors (Grosschedl
et al., 1994; Giese et al., 1995; Bianchi and Beltrame, 1998).
Because of this bending ability and the observation that
TCF factors cannot directly activate transcription in re-
porter assays, it has been proposed that TCF/LEF family
members primarily serve an architectural function. LEF-1
appears unique in that it contains a context-dependent
activation domain (CAD) (Carlsson et al., 1993), which can
activate transcription in the presence of the coactivator
ALY (Bruhn et al., 1997). The other TCF family members do
not appear to contain a CAD domain (van de Wetering et
al., 1996).
TCF/Lef mRNAs undergo extensive alternative splicing.
The best studied gene, TCF-1, also exhibits alternative
promoter usage. Over 100 Tcf-1 isoforms may theoretically
be produced. However, Western blotting has revealed the
predominant expression of eight different TCF-1 protein
isoforms (van de Wetering et al., 1996). LEF-1 exhibits two
splice variants (Waterman et al., 1991) and also possesses
two promoters (Hovanes et al., 2001). Several C-terminal
splice variants exist of TCF-4 that exhibit strong sequence
homology to similar TCF-1 mRNAs (Korinek et al., 1997;
Duval et al., 2000) (Fig. 1). While the functional relevance of
the alternative splice products in TCF/Lef genes remains
unclear at present, alternative promoter usage in the TCF-1
and LEF-1 gene generates protein isoforms that either carry
or lack the N-terminal -catenin interaction domain (see
below).
TCF/LEF KNOCKOUT MICE
The molecular context in which the TCF family of
transcription factors functions remained mysterious for
years. Knockout mice have been generated for three murine
Tcfs. In adult animals, Tcf-1 is expressed in T lymphocytes.
Indeed, Tcf-1/ knockout mice are impaired in the genera-
tion of T lymphocytes (Verbeek et al., 1995). Their thy-3584 CX Utrecht, The Netherlandsmuses are reduced in size and show a 10- to 100-fold
1
reduction in T cell numbers compared with heterozygous
littermates (Verbeek et al., 1995). Nevertheless, the Tcf-1/
mice are fully immunocompetent, have functional periph-
eral T cells, have a normal lifespan, and are fertile
(Schilham et al., 1998). Closer examination of the thymo-
cytes from 4- to 6-week-old animals revealed proliferative
abnormalities at several precursor stages, which are nor-
mally characterized by extensive cell expansion (Schilham
et al., 1998). However, mature T cells as present in spleen
and lymph nodes are fully competent upon encountering
mitogens or antigens. Tcf-1 thus appears essential for the
maintenance of early thymocyte progenitors.
More recently, it was found that Tcf-1/ mice develop
adenomas in the gut and the mammary glands. This led to
the hypothesis that Tcf-1 is a target gene of Tcf-4/-catenin
signaling in the intestine (Roose et al., 1999). The predomi-
nantly expressed isoform of Tcf-1 in the gut lacks the
N-terminal -catenin interaction domain and may function
in a negative feedback loop.
Lef-1/ knockout mice have a more complex phenotype.
During embryogenesis, Lef-1 is expressed at many different
sites, including the tel-, di-, and mesencephalon, tooth
germs, whisker follikels, mammary buds, thymus, limb
buds, and tail vertebrae (Oosterwegel et al., 1993; Zhou et
al., 1995; van Genderen et al., 1994). Mice homozygous for
a mutation in the Lef gene die shortly after birth and show
deficiencies in some but not all organs normally expressing
Lef-1 (van Genderen et al., 1994). Most strikingly, these
mice lack body hair and whiskers. Although follicle forma-
tion starts at the proper time point, only one-third of
normal hair follicle numbers is found later in development.
These hair follicles are short and rudimentary. These
Lef-1/ mice also lack teeth. The tooth germs are indistin-
guishable from wild-type counterparts at the bud stage
(E13). Yet, normal progression of the Lef-1/ buds to the
late cap stage (E15) is halted (van Genderen et al., 1994).
Newborn Lef1/ females reveal a stunted development of
mammary glands. The mutant mice also lack the trigemi-
nal nucleus. Unexpectedly, the mice did not show any
obvious defects in lymphoid cell populations at birth,
despite the fact that Lef-1 is expressed in B-cells (van
Genderen et al., 1994). Nevertheless, it was shown in a
recent study that Lef-1 mediates proliferation of early B
lineage cells in vitro (Reya et al., 2000).
Tcf-1/Lef-1 double knockout mice made with a hypomor-
phic Tcf-1 allele display a very severe defect in T cell
differentiation, but no developmental defects. / T cell
differentiation is completely blocked at the immature
single positive (ISP) stage and clearly impaired at earlier
stages (Okamura et al., 1998). Crossing a null-allele of Tcf-1
into Lef-1 knockout mice yields an early embryonic pheno-
type that resembles that of Wnt-3A. Severe defects occur in
the differentiation of the paraxial mesoderm, resulting in
the formation of additional neural tubes. These embryos
FIG. 1. Schematic representation of Tcf splice variants and their most conserved domains. Short forms of Tcf-1 lack the N-terminal
domain, which interacts with -catenin. The most distinct regions of the Tcf family members is the C terminus, which contains the
CRARF domain in the longer versions.
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also show defects in placenta formation and in the forma-
tion of the apical ectodermal ridge of the limb buds. These
data indicate extensive functional redundancy between
Tcf-1 and Lef-1 in early T lymphocytes and during embry-
onic development (Galceran et al., 1999).
Tcf-4 is expressed from E10.5 onward in the developing
CNS, where it partially overlaps with Lef-1 expression.
Tcf-4 expression is particularly striking in gut epithelium
throughout life (Korinek et al., 1997, 1998a). Tcf-4/ mice
die shortly after birth and display a single phenotypic
abnormality, the complete absence of the stem cell com-
partment in the crypts of the small intestine (Korinek et al.,
1998b). The organization of the pseudostratified epithelium
in the small intestine of mutant embryos shows no aberra-
tions at day 14.5 compared with control littermates. At day
16.5, however, a reduced number of cells populates the
prospective crypt region and the number of villi is reduced
(Korinek et al., 1998b). Closer examination of the cells
populating the prospective crypt regions reveals a lack of
actively dividing crypt cells, implying that Tcf-4, like Tcf-1,
functions to maintain early progenitor cells.
BINDING PARTNERS OF TCF
The identification of binding partners of TCF/LEF even-
tually revealed their molecular context. The first protein
found to interact with TCF/LEF factors was the Wnt signal-
ing effector -catenin (Molenaar et al., 1996; Behrens et al.,
1996). Using multimerized TCF binding motifs upstream of
a reporter gene, it became apparent that cotransfection of
TCF with -catenin strongly induced transcription (Mo-
lenaar et al., 1996). All members of the TCF family can bind
-catenin through a conserved N-terminal stretch of 55
amino acids. -Catenin thus functions as a classical coac-
tivator of transcription. A potent transcriptional activation
domain maps to its C terminus. Recent studies have indi-
cated that this domain serves to modify local chromatin.
The histone acetylase CBP was found to interact directly
with the transactivation domain of -catenin and syner-
gizes with the latter protein to enhance transcription of a
reporter gene in vivo (Takemaru and Moon, 2000). Simi-
larly, the C-terminal transactivation domain of -catenin
binds to Brg-1, a core component of the mammalian Swi/
Snf chromatin remodeling complex. Binding of Brg-1 to
-catenin enhances transcription of Tcf target genes (Barker
et al., 2001).
Another binding partner of TCF, Grg-5, is related to
Drosophila Groucho, which in turn is the founding member
of a family of broadly expressed transcriptional corepres-
sors. Grg proteins interact with histone deacetylase-1
(HDAC) and can thus mediate the condensation of chroma-
tin (Chen et al., 1999). In a transient reporter assay, the
transcription driven by -catenin/TCF could completely be
repressed by coexpression of Grg expression constructs
(Roose et al., 1998; Cavallo et al., 1998). In mammals, all
members of the TCF family can bind to all Grgs; the
combinations appear to be equally potent in repressing
transcription (Brantjes et al., 2001). The shorter Grg family
member, Grg-5, fails to bind to HDAC, acting thereby as a
derepressor (Roose et al., 1998; Brantjes et al., 2001).
In Drososphila, another repressor of -catenin/TCF was
identified as CBP (Waltzer and Bienz, 1998). This was rather
surprising, as CBP is a strong coactivator for dozens of other
transcription factors, including -catenin. CBP binds to the
HMG box and subsequently acetylates a specific lysine in
the N-terminal -catenin interaction domain. This leads to
decreased binding of -catenin to TCF, resulting in lower
transactivation. The lysine to be acetylated, K25, is absent
from the N termini of TCF-1, TCF-3, and the worm POP-1.
This suggests that this mode of modulating -catenin/Tcf-
mediated signaling may be dependent on the identity of the
TCF/Lef family member. The phenotype of the dCBP mu-
tant embryos suggests that this activity of dCBP primarily
antagonizes Wnt signaling in cells which are only stimu-
lated weakly (Waltzer and Bienz, 1998). Finally, another
protein found to function as corepressor for a subset of the
TCF family was described by Moon and coworkers (Bran-
non et al., 1999). C-terminal binding protein (CtBP) binds to
a sequence only present in the C terminus of XTcf-3 and
TCF-4, thereby converting these TCF proteins into repres-
sors.
Taken together, TCFs act as repressors in the absence of
Wnt signaling (see below) by complex formation with one of
several corepressors. Transcriptional repression involves
histone deacetylation, but may utilize other yet unidenti-
fied mechanisms. Upon the delivery of a Wnt signal, com-
plex formation with -catenin recruits histone acetylases
(CBP) and chromatin remodelers (Brg1) to TCF target genes
to transiently activate their transcription.
TCF AND WNT-SIGNALING
The identification of -catenin as a binding partner of
TCF answered two questions at once. It provided a mecha-
nism by which TCF could regulate transcription, and also
revealed the nature of the final step in the Wnt cascade.
-Catenin was the most downstream protein in the Wnt-
signaling cascade known at the time, but it was unclear
how -catenin was able to transduce the signal into the
nucleus, as -catenin has no DNA-binding properties. TCF,
on the other hand, was known to bind to DNA, but by itself
did not regulate transcription. Now that -catenin and TCF
were found to interact, TCF could be placed downstream of
-catenin in the Wnt-signaling cascade.
THE CORE OF THE WNT PATHWAY
The Wnt/wingless proteins constitute a large family of
cysteine-rich glycoproteins. Wnts function as ligands for
members of the Frizzled (Fz) family of serpentine recep-
tors (Bhanot et al., 1996). Low-density lipoprotein (LDL)
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receptor-related proteins (LRPs) act in synergy with Fz. The
extracellular domains of both proteins interact, and signal-
ing of Wnt is only mediated when both Fz and LRP are
complexed with Wnt-1 (Tamai et al., 2000; Wehrli et al.,
2000; Pinson et al., 2000).
In unstimulated cells, -catenin resides in a large cyto-
plasmic complex consisting of the tumor suppressor APC
(adenomatous polyposis coli), GSK-3 (glycogen synthase
kinase 3), and Axin (Behrens et al., 1998; Kishida et al.,
1998; Ikeda et al., 1998). In this destruction complex,
-catenin is phosphorylated by the serine/threonine kinase
GSK-3 on four N-terminal serine and threonine residues.
The phosphorylated residues are recognized by -TrCP,
which resides in an E3 ubiquitin ligase complex. Ubiquiti-
nation of -catenin induces its rapid proteasomal degrada-
tion (Orford et al., 1997). Upon Wnt binding to its receptors,
the Wnt-signaling cascade is activated (Fig. 2). This results
in inhibition of the constitutive activity of GSK-3 (Sieg-
fried et al., 1994; Dominguez et al., 1995; He et al., 1995;
Cook et al., 1996). Consequently, -catenin is no longer
phosphorylated and can accumulate in the cytoplasm and
nucleus (Funayama et al., 1995; Schneider et al., 1996; Yost
et al., 1996). Nuclear -catenin interacts with members of
the TCF family, resulting in target gene transcription (Mo-
lenaar et al., 1996; Brunner et al., 1997; Riese et al., 1997;
van de Wetering et al., 1997). (For a more detailed descrip-
tion of the Wnt signaling cascade see reviews in Wodarz and
Nusse, 1998; Miller et al., 1999; Polakis, 2000; Peifer and
Polakis, 2000.)
The involvement of TCF/LEF in the Wnt-signaling path-
way was first addressed in Xenopus laevis. The role of
-catenin in dorsal axis formation had been known for years
(Heasman et al., 1994). Ventral microinjection of -catenin
mRNA in embryos induces axis duplication. This pheno-
type could be prevented by coinjecting mRNA encoding an
XTcf-3 protein lacking the -catenin binding domain. Dor-
sal injection of this Tcf mutant could also block endoge-
nous head induction (Molenaar et al., 1996). Injections of
Lef-1 mRNA lacking the HMG box also inhibited head
induction (Behrens et al., 1996; Huber et al., 1996). These
data proved that the direct interaction of -catenin with
TCF/LEF is essential for normal axis specification in Xeno-
pus and tentatively placed TCF/LEF directly downstream of
-catenin in the Wnt cascade.
Since the experiments in Xenopus largely relied on over-
expression of proteins, definitive proof of the role of Tcf in
the Wnt signaling cascade was subsequently sought from
genetic experiments in Drosophila. Two labs independently
cloned the fly homologue of Tcf, dTcf or pangolin (van de
Wetering et al., 1997; Brunner et al., 1997). dTcf binds a Tcf
DNA motif and, together with the fly -catenin homologue
armadillo, transactivates transcription of reporter genes.
FIG. 2. Model of the Wnt signaling cascade. This simplified scheme depicts the differences between a nonsignaling cell and its signaling
counterpart.
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The isolation of dTcf-mutant flies revealed segment polar-
ity phenotypes as expected for Wnt pathway mutants.
Loss-of-function mutations in dTcf were dominant over
gain-of-function mutations in armadillo (van de Wetering
et al., 1997), confirming the observations in X. laevis (see
above). Moreover, murine Lef-1 overexpression in trans-
genic flies was found to mimic hyperstimulation of the Wnt
pathway (Bruhn et al., 1997).
Studies in the nematode C. elegans on the role of
-catenin and TCF were complicated for two reasons. First,
at least two different Wnt signal transduction cascades
exist. Second, the C. elegans genome harbors three
-catenin homologues: WRM-1, BAR-1, and HMP-2. Wnt
signaling was originally studied in the specification of the
endoderm (E) and mesoderm (MS) cells from a common
precursor (EMS) at the four- to eight-stage. In this pathway,
the -catenin homologue WRM-1 unexpectedly opposes the
activity of the Tcf homologue POP-1. This activity requires
the formation of a ternary complex with the MAP kinase-
like LIT-1 protein (Lin et al., 1995; Rocheleau et al., 1999).
Reinterpretation of these data suggests that, in the EMS
Wnt pathway, the Tcf homologue POP-1 only acts as a
repressor. Activation of LIT-1/WRM1 by Wnt signaling
results in the inactivation of the repressive POP-1. This
alternative Wnt pathway may also exist in mammals (Ishi-
tani et al., 1999).
More recently published data demonstrate that a canoni-
cal Wnt signaling pathway does exist in C. elegans. The
pathway utilizes one of the other -catenin homologs,
BAR-1, in conjunction with the Tcf homologue POP-1.
BAR-1 acts like -catenin in activating target genes in
response to Wnt signals. Developmental events controlled
by BAR-1/POP-1 in this canonical Wnt pathway include
vulva development and migration of a specific neuron, the
Q cell, and its offspring (Korswagen et al., 2000).
MUTATIONAL ACTIVATION
OF TCF IN CANCER
Wnt-1 was first identified by retroviral integration in
mammary tumors in mice, implying that Wnt-signaling
plays a role in tumor development. Wnts do not appear to
play a dominant role in human cancer. Rather, mutations in
downstream components of the Wnt cascade are a major
cause of several types of cancer. APC is mutated at both
alleles in 80% of all colon carcinomas (Polakis et al., 1999).
These mutations almost invariably lead to a truncation of
APC, removing its interaction domains for -catenin and
axin. As a consequence, the activity of the destruction
complex is impaired and cytosolic -catenin is no longer
phosphorylated and degraded, but rather accumulates. The
accumulated -catenin in turn inappropriately activates
one of the TCF/LEF family members that is specifically
expressed in the intestinal epithelium, TCF-4 (Korinek et
al., 1997). In a significant fraction of sporadic colon tumors
lacking APC mutations, mutations were found in the
CTNNB1 (-catenin) gene. These mutations occur in or
around the third exon, which encodes the putative phos-
phorylation sites of GSK-3 and remove the target residues
of this kinase (Morin et al., 1997; Polakis et al., 1999).
Mutations in -catenin are not only found in intestinal
tumors. The CTNNB1 gene has been sequenced extensively
in various other tumors. An overview of the mutations
found in -catenin can be found at the Wnt-signaling
website (www.ana.ed.ac.uk/rnusse/pathways/bcatmut.html).
As the exception that proves the rule, rare mutations in
Axin/Conduction have also been found in colon tumors and
other types of malignancies (Webster et al., 2000).
Taken together, mutations in APC, axin, and -catenin
share a common denominator, in that they all lead to the
formation of -catenin/TCF complexes. This implies that
the inappropriate activation of TCF target genes in epithe-
lial cells represents the primary event in cellular transfor-
mation (reviewed in Polakis, 2000; Fodde and Smits, 2001).
THE BIOLOGY OF INTESTINAL
CRYPT CELLS
Why would the inappropriate activation of TCF provide
such a potent transforming signal? These data imply an
important role for TCF-4 in the physiology of the intestinal
epithelium. This epithelium consists of alternating crypts
and villi (Potten and Loeffler, 1990). The proliferating stem
cell population is located in the crypts, from which cells
slowly migrate up toward the villus. These cells differenti-
ate into various distinct cell types. Once reaching the apex
of the villus, the cells die and are shed into the gut lumen.
A Wnt signal activates Tcf-4 to instruct epithelial cells to
adopt a stem cell phenotype. It is obvious how the inappro-
priate activation of Tcf-4 would result in the unrestrained
proliferation of undifferentiated cells. Abnormal outpock-
eting of the intestinal epithelium at the crypt-villus border
is the first sign of polyp formation. This pocket protrudes
into the inside of the neighboring villus, subsequently
filling the total space. APC loss and the subsequent stabi-
lization of -catenin results in an increase in size of the
proliferative compartment in the crypt region. As Tcf4
expression is required for crypt maintenance, it is likely
that inappropriate Tcf4/-catenin signaling is responsible
for this phenomenon. Cells that normally would start to
differentiate when migrating up the crypt-villus axis now
are kept in a proliferative and nondifferentiated state; in
other words, they remain crypt cells. This is supported by
the fact that -catenin has been observed to suppress
differentiation (Harada et al., 1999).
A number of TCF target genes have been proposed to play
a role in the transformation of intestinal epithelial cells.
These include c-MYC (He et al., 1998), cyclin D1 (Tetsu and
McCormick, 1999), TCF-1 (Roose et al., 1999), gastrin (Koh
et al., 2000), and PPAR (He et al., 1999). For a complete list
visit the Wnt website: www.ana.ed.ac.uk/rnusse/wntwindow.
html. Although these target genes may play a role in
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cellular transformation, these studies provide only snap-
shots of the entire TCF target gene program in colorectal
cancer. Global insights into this genetic program will
undoubtedly be generated in the near future through the
application of DNA array analysis.
The detailed molecular understanding of the Wnt-
signaling cascade now allows the search for drugs that
selectively target specific steps of the pathway. Structures
of the -catenin/Tcf3 and -catenin/E-cadherin complexes
have recently been elucidated (Graham et al., 2000; Huber
and Weis, 2001). Birchmeier and colleagues have performed
an extensive mutational analysis of the basic groove that
runs along the length of the armadillo-repeat region of
-catenin (von Kries et al., 2000). This groove binds Tcf,
E-cadherin, and APC in a mutually exclusive fashion. In
addition, it binds axin. This study revealed unique hotspots
in the groove for each of these four interaction partners.
This has raised hopes that unique inhibitors can be de-
signed for the -catenin/Tcf interaction. Such inhibitors
may constitute highly precise drugs for the treatment of
colorectal cancer.
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